关键词: children concurrent screening genetic screening hearing loss newborn hearing screening

来  源:   DOI:10.3389/fped.2023.1222324   PDF(Pubmed)

Abstract:
Hearing loss is one of the most common sensory disorders in humans. The purpose of this review is to summarize the history and current status of newborn hearing screening in China and to investigate future developmental trends in newborn hearing screening with the intention of sharing experiences and providing a reference for other populations. In the 1980s, the research on hearing monitoring for high-risk infants led to the gradual development of newborn hearing screening in China. With the continuous improvement of screening technology, the newborn hearing screening program was gradually extended to the whole country and became a government-led multidisciplinary public health program. Genetic screening for deafness has been incorporated into newborn hearing screening in many regions of China to help screen for potential and late-onset deafness in newborns. In the future, it is necessary to further establish and improve whole life-cycle hearing screening and healthcare, conduct screening for congenital cytomegalovirus infection, and create a full-coverage, whole life course hearing screening and intervention system. Screening for deafness in China has been marked by 40 years of achievements, which have been a source of pride for entrepreneurs and comfort for patients and their families. Managing hearing screening data information more efficiently and establishing a quality control index system throughout the whole screening process are of paramount importance. The genetic screening for concurrent newborn hearing and deafness has a great clinical importance for the management of congenital deafness and prevention of ototoxicity. A hearing screening and intervention system across the whole life course should be developed.
摘要:
听力损失是人类最常见的感觉障碍之一。本文旨在总结我国新生儿听力筛查的历史和现状,探讨未来新生儿听力筛查的发展趋势,分享经验,为其他人群提供参考。在1980年代,高危儿听力监测的研究带动了我国新生儿听力筛查的逐步发展。随着筛分技术的不断改进,新生儿听力筛查计划逐渐扩展到全国,成为政府主导的多学科公共卫生计划。在中国许多地区,耳聋基因筛查已被纳入新生儿听力筛查中,以帮助筛查新生儿的潜在和迟发性耳聋。在未来,有必要进一步建立和改善全生命周期的听力筛查和医疗保健,进行先天性巨细胞病毒感染筛查,并创建一个全覆盖,终身听力筛查和干预系统。我国耳聋筛查已有40年的成就,这是企业家的骄傲和患者及其家人的安慰。更有效地管理听力筛查数据信息,建立贯穿整个筛查过程的质量控制指标体系至关重要。新生儿听力和耳聋的遗传筛查对于先天性耳聋的治疗和耳毒性的预防具有重要的临床意义。应建立贯穿整个生命历程的听力筛查和干预系统。
公众号